U.S. employers are restructuring corporate healthcare plans as expenditure on GLP-1 weight-loss medications threatens to expand annual benefit budgets by up to 15%.
Cost Containment Policies
Human resource departments are introducing strict prior-authorization protocols and lifestyle management mandates before approving coverage. Some self-insured corporations have opted to cap annual prescription expenditures per employee to preserve core health benefits.
Long-Term Productivity Offsets
Actuarial data suggests that long-term reduction in cardiovascular events and diabetes management could offset initial drug costs within four to six years. However, high short-term cash outlays remain a key concern for mid-sized enterprise financial executives.